Management of Recombinant Human Growth Hormone Therapy at Puberty

Publisher： Karger

E-ISSN： 1663-2826|49|2|58-61

ISSN： 1663-2818

Source： Hormone Research in Paediatrics, Vol.49, Iss.2, 2004-11, pp. : 58-61

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recombinant Human Growth Hormone Therapy in Infants with Chronic Renal Failure

By  

Hormone Research in Paediatrics, Vol. 49, Iss. 1, 2004-11 ,pp. : 49-50

Karger

Access to resources Recommend Favorite

Recombinant Human Growth Hormone Therapy in Children with Chromosome 15q26 Deletion

By  

Hormone Research in Paediatrics, Vol. 83, Iss. 6, 2015-04 ,pp. : 424-430

Karger

Access to resources Recommend Favorite

Use of Recombinant Human Growth Hormone in Children with Thalassemia

By  

Hormone Research in Paediatrics, Vol. 71, Iss. 1, 2009-01 ,pp. : 46-50

Karger

Access to resources Recommend Favorite

Safety of High Doses of Recombinant Human Growth Hormone

By  

Hormone Research in Paediatrics, Vol. 49, Iss. 2, 2004-11 ,pp. : 78-81

Karger

Access to resources Recommend Favorite

Recombinant Human Growth Hormone Plus Recombinant Human Insulin-Like Growth Factor-1 Coadministration Therapy in Short Children with Low Insulin-Like Growth Factor-1 and Growth Hormone Sufficiency: Results from a Randomized, Multicenter, Open-Label, Parallel-Group, Active Treatment-Controlled Trial

By  

Hormone Research in Paediatrics, Vol. 83, Iss. 4, 2015-03 ,pp. : 268-279

Karger

Access to resources Recommend Favorite